Infantile Krabbe disease (0-12 months), progression, and recommended endpoints for clinical trials.
- DOI
- 10.1002/acn3.52114
- Published
- 2024 Dec
- Container
- Annals of clinical and translational neurology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/acn3.52114,
title = {Infantile Krabbe disease (0-12 months), progression, and recommended endpoints for clinical trials.},
author = {Greco MR and Lopez MA and Beltran-Quintero ML and Tuc Bengur E and Poe MD and Escolar ML},
year = {2024},
journal = {Annals of clinical and translational neurology},
doi = {10.1002/acn3.52114},
url = {https://doi.org/10.1002/acn3.52114}
}RIS
TY - JOUR TI - Infantile Krabbe disease (0-12 months), progression, and recommended endpoints for clinical trials. AU - Greco MR AU - Lopez MA AU - Beltran-Quintero ML AU - Tuc Bengur E AU - Poe MD AU - Escolar ML PY - 2024 JO - Annals of clinical and translational neurology DO - 10.1002/acn3.52114 UR - https://doi.org/10.1002/acn3.52114 ER -
APA
MR, G., MA, L., ML, B., E, T. B., MD, P., & ML, E. (2024). Infantile Krabbe disease (0-12 months), progression, and recommended endpoints for clinical trials.. Annals of clinical and translational neurology. https://doi.org/10.1002/acn3.52114
Source records
- pubmed · retrieved 2026-09-26T10:56:01.032Z